ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair

American Journal of Pathology

Volumn 173, Issue 3, 2008, Pages 643-652

  Yates, Cecelia C ^a,b   Whaley, Diana ^a   Y Chen, Amy ^a,c   Kulesekaran, Priya ^a,d   Hebda, Patricia A ^a   Wells, Alan ^a,b,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b TUSKEGEE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COLLAGEN TYPE 4; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; KALININ; LIGAND; THROMBOCYTE FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CHEMOTAXIS; CONTROLLED STUDY; DERMIS; DISEASE MODEL; EPIDERMIS CELL; EPITHELIUM CELL; EPITHELIZATION; FEMALE; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CELL; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 51349099867     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070990     Document Type: Article

References (28)

1. Rosenkilde MM, Schwartz TW: The chemokine system - a major regulator of angiogenesis in health and disease. APMIS 2004, 112:481-495
2. Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A: Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am J Pathol 2007, 171:484-495
3. Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P: An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC and acts as functional receptor for platelet factor 4. J Exp Med 2003, 197:1537-1549
4. Yamamoto T, Chikugo T, Tanaka Y: Elevated plasma levels of β-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis. Clin Rheumatol 2002, 21:501-504
5. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R: Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998, 153:1849-1860
6. Tensen CP, Flier J, vanderRaaij-Helmer EM, Sampat-Sardjoepersad S, vanderSchors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R: Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 1999, 112:716-722
7. Satish L, Yager D, Wells A: ELR-negative CXC chemokine IP-9 as a mediator of epidermal-dermal communication during wound repair. J Invest Dermatol 2003, 120:1110-1117
8. Shiraha H, Gupta K, Glading A, Wells A: IP-10 inhibits epidermal growth factor-induced motility by decreasing epidermal growth factor receptor-mediated calpain activity. J Cell Biol 1999, 146:243-253
9. Bodnar RJ, Yates CC, Wells A: IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ Res 2006, 98:617-625
10. Smith KD, Wells A, Lauffenburger DA: Multiple signaling pathways mediate compaction of the collagen matrices by EGF-stimulated fibroblasts. Exp Cell Res 2006, 312:1970-1982
11. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir A-M, Neyts J, Liekens S, Maudgal PC, Billiau A, Van Damme J: Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 2001, 98:3554-3561
12. Satish L, Blair HC, Glading A, Wells A: IP-9 (CXCL11) induced cell motility in keratinocytes requires calcium flux-dependent activation of μ-calpain. Mol Cell Biol 2005, 25:1922-1941
13. Byrne C, Fuchs E: Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol Biol Cell 1993, 13:3176-3190
14. Hebda PA, Whaley D, Kim H-G, Wells A: Absence of inhibition of cutaneous wound healing in mice by oral doxycycline. Wound Repair Regener 2003, 11:373-379
15. Greenhalgh DG: FACS: models of wound healing. J Burn Care Rehab 2005, 26:293-305
16. Fuchs E: Keratins and the skin. Annu Rev Cell Dev Biol 1995, 11:123-154
17. Boulday G, Haskova Z, Reinders MEJ, Pal S, Briscoe DM: Vascular endothelial growth factor-induced signaling pathways in endothelial cells that mediate overexpression of the chemokine IFN-{gamma}-inducible protein of 10 kDa in vitro and in vivo. J Immunol 2006 Mar 1 176(5) 1; pp 3098-3107
18. Babu M, Wells A: Dermal-epidermal communication in wound healing. Wounds 2001, 13:183-189
19. Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, Jensen B, Madsen HO, Ryder LP, Svejgaard A, Malling H-J, Skov PS, Poulsen LK: CXC chemokine receptor 3 expression on CD34 hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 2000, 96:1230-1238
20. Lazzeri E, Romagnani P: CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune, Endocrine, Metabolic Disord 2005, 5:109-118
21. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker E-B, Gillitzer R: Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998 Dec; 153(6); pp 1849-1860
22. Del Rio M, Larcher F, Meana A, Segovia JC, Alvarez A, Jorcano JL: Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter. Gene Ther 1999, 6:1734-1741
23. Tyner AL, Fuchs E: Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis. J Cell Biol 1986, 103:1945-1955
24. Shiraha H, Glading A, Chou J, Jia Z, Wells A: Activation of m-calpain (calpain II) by epidermal growth factor is limited by PKA phosphorylation of m-calpain. Mol Cell Biol 2002, 22:2716-2727
25. Allen FD, Asnes CF, Chang P, Elson EL, Lauffenburger DA, Wells A: EGF-induced matrix contraction is modulated by calpain. Wound Repair Regener 2002, 10:67-76
26. Gillitzer R, Goebeler M: Chemokines in cutaneous wound healing. J Leukoc Biol 2001, 69:513-521
27. Flier J, Boorsma DM, vanBeek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP: Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001, 194:398-405
28. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, King JA, Smiley ST, Ling M, Gerard NP, Gerard C: Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000, 192:1515-1520